微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
RSS 官方收录 · 可信分层展示
关键摘要
The Food and Drug Administration says it is developing a plan for how to regulate medical devices that use generative artificial intelligence.…
- The FDA will eventually release documents spelling out agency policies…
- “Our goal is formal policy guidance,” he said in an interview.
- “The ecosystem is expecting clarity.
摘要引擎：抽取
正文提要
The Food and Drug Administration says it is developing a plan for how to regulate medical devices that use generative artificial intelligence.
The FDA will eventually release documents spelling out agency policies regarding the technology, Rick Abramson, director of the agency’s Digital Health Center of Excellence, told STAT.
“Our goal is formal policy guidance,” he said in an interview. “The ecosystem is expecting clarity. We seek to provide that clarity, and I’ll also throw in that I think the ecosystem can expect not only broad guidance on the overall topic of generative AI, but also some more narrowly constructed specialty guidance on particular generative AI topics of special interest or special complexity.”